Periscope Capital’s Longevity Acquisition Corporation Right LOACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-150,000
Closed -$38K 469
2020
Q3
$38K Sell
150,000
-62,068
-29% -$14.2K ﹤0.01% 288
2020
Q2
$42K Buy
212,068
+107,893
+104% +$16.7K ﹤0.01% 230
2020
Q1
$16K Hold
104,175
﹤0.01% 232
2019
Q4
$19K Hold
104,175
﹤0.01% 232
2019
Q3
$21K Hold
104,175
﹤0.01% 222
2019
Q2
$31K Buy
104,175
+3,575
+4% +$757 ﹤0.01% 198
2019
Q1
$25K Buy
100,600
+20,000
+25% +$4.52K ﹤0.01% 163
2018
Q4
$24K Buy
+80,600
New +$30.5K ﹤0.01% 169

Other funds holding LOACR

Periscope Capital's LOACR Position: Q4 2020 in Review

Periscope Capital sold out of Longevity Acquisition Corporation Right (LOACR) in Q4 2020, closing a stake of 150,000 shares — an estimated $38K sold.

Periscope Capital first reported a position in LOACR in Q4 2018 and held it in 8 quarters. The position peaked at $42K in Q2 2020. 7 funds tracked by Wall St. Rank hold LOACR as of Q4 2020.

  • Periscope Capital reported no remaining Longevity Acquisition Corporation Right position as of Q4 2020 after selling out during the quarter.
  • Periscope Capital sold 150,000 Longevity Acquisition Corporation Right shares in Q4 2020, an estimated $38K.
  • Periscope Capital first reported a position in Longevity Acquisition Corporation Right in Q4 2018 and held it in 8 quarters.
  • Periscope Capital's Longevity Acquisition Corporation Right position peaked at $42K in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Right as of Q4 2020.

Based on Periscope Capital's 13F filing for Q4 2020, filed 10 Feb 2021.